Advancing Prenatal Drug Safety by integrating Microfluidic Fraction Collectors: A Breakthrough from MIC and i3S
A New Era for Prenatal Drug Testing
The LIFESAVER project is revolutionizing drug safety for expectant mothers and their unborn children, addressing a critical gap in pharmaceutical development. Traditional methods for testing drug safety often fail to capture the dynamic, time-resolved effects of medications on developing cells, especially in the context of pregnancy.
Enter the microfluidic fraction collector—a cutting-edge tool developed by the Microfluidics Innovation Center (MIC) and tested by MIC and the Institute for Research and Innovation in Health (i3S), both partners in the LIFESAVER project. This application note, Fraction Collector for Microfluidic Cell Culture, demonstrates how automated, precise sample collection from microfluidic cell cultures can transform prenatal drug testing, supporting the development of safer medications for pregnant women and their babies.
The Problem LIFESAVER Tackles
Pregnancy introduces unique physiological challenges, and the effects of medications—whether antidepressants, pain relievers, or hormone therapies—can vary dramatically over time. LIFESAVER aims to support drug safety and efficacy for both mother and fetus, providing pharmaceutical innovators with reliable data to assess the physiological impact of medications during pregnancy. Without time-resolved insights into how drugs interact with developing cells, developers risk missing critical safety signals, potentially leading to adverse outcomes.
How the Microfluidic Fraction Collector Helps
The application note from MIC and i3S showcases a microfluidic cell perfusion setup with an inline fraction collector, capable of collecting up to 20 samples at volumes (10-1500 µl) and intervals defined by the user, shown here as 150 µl samples hourly over 20 hours with high accuracy (152.6 ± 1.3 µl, <2% variation). This system allows researchers to analyze sequential fractions for molecular changes, such as metabolism, transport and uptake/release, which are critical for understanding a drug’s impact on placental or fetal cells. By automating sample collection, the fraction collector eliminates manual errors and enables high-throughput, time-resolved studies—perfectly aligning with LIFESAVER’s goal of generating robust data for prenatal drug safety.
For example, this technology can enable tracking of how antidepressants are metabolized by placental cells over time, revealing potential risks to fetal development or maternal physiology. The combined expertise of MIC in microfluidics and i3S in biomedical research ensures that this tool is reliable, repeatable, and ready for real-world applications in drug development.
Why This Matters for Prenatal Safety
The precision and automation of the fraction collector is a module that advances the capabilities of perfusion cell models, empowering researchers to study the physiological effects of drugs in a controlled, in vitro environment that mimics in vivo conditions, providing critical data to support safer treatments that improve the safety of both mother and child.
A Call to Pharmaceutical Innovators
This innovative project, funded by the European Union’s Horizon 2020 program, is paving the way for a future where prenatal drug safety is no longer an afterthought. The microfluidic fraction collector is a testament to how innovation can address complex challenges in drug development. To pharmaceutical innovators committed to advancing drug safety for expectant mothers and their unborn children, this technology offers a path to lead the way in prenatal safety innovation—because safety, efficacy, and overall well-being matter.
Get Involved: Join the Movement for Change
Want to learn more about LIFESAVER’s work and how we’re contributing to a zero-pollution future?
- Follow Us: Stay updated on our progress through our website and social media channels.
- Collaborate: Join us at workshops, conferences, and GD-SO networking events to explore synergies and share knowledge.
- Spread the Word: Share this blog post and help us raise awareness about the importance of animal-free testing for a sustainable future.
Together, we can build a cleaner, safer, and more ethical Europe—one where science and sustainability go hand in hand.
For more insights into how LIFESAVER leverages such innovative research to enhance prenatal safety, visit the LIFESAVER project’s website. Here, you can also find updates on other research outputs and initiatives under the LIFESAVER umbrella, driving forward the frontier of maternal and fetal health safety.
